Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
02/2004
02/04/2004CN1137383C Human RTN 4B protein and code sequence and its preparation and use
02/04/2004CN1137266C Novel DNA polymerase
02/04/2004CN1137265C Method for raising plant nitrogen assimilation efficiency
02/04/2004CN1137264C Specific DNA sequence of oriental vole and its use
02/04/2004CN1137263C ATP sensitive potassium channel gene defective animal tissues and cells
02/04/2004CN1137262C Mutants of Rb and P53 genes and uses thereof
02/04/2004CN1137261C Punctiform aerogenic monad prolyl endopeptidase and its preparation method and application
02/04/2004CN1137139C Process for producing recombined lymphotoxin derivative
02/04/2004CN1136920C Gene transfer-mediated angiogenesis therapy
02/04/2004CN1136918C Vaccines
02/04/2004CN1136917C TB vaccine heat reversal protein 65 and multiepi-position HER-2 Antigen fusion protein recombinat protein vaccine
02/04/2004CN1136914C Method for identifying or isolating molecule and molecules identified therby
02/03/2004US6686516 Expression of trehalose 6-phosphate synthase in plant plastids
02/03/2004US6686515 Homologous recombination in plants
02/03/2004US6686514 Nucleotide sequences coding enzymatic polypeptide for use in the foods, adhesives, textiles, fertilizers, medicine, cosmetics and papermaking
02/03/2004US6686513 Ubi9=(poly)ubiquitin gene promoter; genetic engineering; cloning; transgenes; polyubiquitin nucleotide sequence useful in regulating expression of other nucleic acid sequences of interest in monocotyledonous and dicotyledonous plants
02/03/2004US6686460 Method and formulation for lyophilizing cultured human cells to preserve RNA and DNA contained in cells for use in molecular biology experiments
02/03/2004US6686459 Mch3 (an apoptotic cysteine protease); genes; nucleotide sequences; functional polypeptide fragments; use of novel cysteine protease modulating programmed cell death-apoptosis-and in therapeutic treatment of human diseases
02/03/2004US6686452 Bacillus thuringiensis CryET29 compositions toxic to coleopteran insects and ctenocephalides SPP
02/03/2004US6686448 Class II cytokine receptor-7
02/03/2004US6686442 Peptide nucleic acid for use in veterinary medicine
02/03/2004US6686388 Regulators of the hedgehog pathway, compositions and uses related thereto
02/03/2004US6686338 Enzyme inhibitors for metabolic redirection
02/03/2004US6686333 Inhibition of HIV replication using soluble Tat peptide analogs
02/03/2004US6686200 Methods and compositions for the large scale production of recombinant adeno-associated virus
02/03/2004US6686199 Transfering nucleotide sequences to animal cells; obtain nuclelotide sequences, administer to animal testes, screen semen and detect transferred nucleotide sequences
02/03/2004US6686196 Useful for regulating transgene expression in cells such as tumor cells and therefore, for therapy of a variety of cancers
02/03/2004US6686192 Antisense RNA expression strategies effective against Streptococcus thermophilus bacteriophages
02/03/2004US6686190 Methods for enhancing the production of viral vaccines in cell culture
02/03/2004US6686188 Polynucleotide encoding a human myosin-like polypeptide expressed predominantly in heart and muscle
02/03/2004US6686186 Mutant fatty acid desaturase
02/03/2004US6686185 Modulating metabolism; cardiovascular disorders
02/03/2004US6686183 Process for the fermentative preparation of D-pantothenic acid and/or its salts
02/03/2004US6686181 Method for the production of L-amino acids from their racemic N-aceytyl-D, L-derivatives by enzymatic racemate cleavage by means of isolated recombinant enzymes
02/03/2004US6686179 Polypeptide for use in the treatment of thrombosis, cancer, inflammation, autoimmune, and bone disorders
02/03/2004US6686178 Fusion proteins; interleukins; colony stimulating factors; cellular proliferation/differentiation; culturing bone marrow or peripheral blood cells; natural killer cells
02/03/2004US6686177 Delayed onset of action
02/03/2004US6686175 IP-10/MIG receptor designated CXCR3, nucleic acids, and methods of use therefor
02/03/2004US6686174 Regulating translation of mrna; reduced risk of developing resistance
02/03/2004US6686168 Producing fusion protein comprising membrane anchor allowing extracellular attachmentin type ii orientation
02/03/2004US6686164 Testing for immunoglobulin e response; for use in foods, detergents, personal care materials
02/03/2004US6686161 Methods and compositions for attachment of biomolecules to solid supports, hydrogels, and hydrogel arrays
02/03/2004US6686160 Analysing genomic dna in sample; obtain nucleotide sequence sample, incubate with oligonucleotide primers, amplify nucleotide sequences, evaluate amplified nucleotide sequences for polymorphisms
02/03/2004US6686157 Signal amplification with lollipop probes
02/03/2004US6686156 Generating copies of preferential nucleotdie sequences; obtain sample nucleotide sequences, hydridize to primers, extend primer, digest and recover preferential sequences
02/03/2004US6686155 Treatment of tumor; obtain tissue sample, extract nucleotide sequences, amplify, detect preferential nucleotide sequences, incbate with antitumor agent, monitor sequence expression, adjustment in expression indicates effective antitumor agent
02/03/2004US6686154 Detecting preferential bacteriophage in a library; obtain target particles, incubate with unclarified culture, propagate, detect viral particle which express preferential fusion protein
02/03/2004US6686153 PRV-1 gene and the use thereof
02/03/2004US6686152 Methods employing oligonucleotide-binding e-tag probes
02/03/2004US6686151 Immunological detection of RNA:DNA hybrids on microarrays
02/03/2004US6686148 Methods for targeting RNA molecules
02/03/2004US6686146 Prognostic methods for prediction of progression of normal and hyperplastic mammary cells to carcinoma
02/03/2004US6685950 Methods of treating viral infections
02/03/2004US6685946 Cold-adapted equine influenza viruses
02/03/2004US6685944 Modification of immunogenic epitopes of the hepatitis c virus core protein to elicit an enhanced immune response
02/03/2004US6685935 Vectors for the diagnosis and treatment of solid tumors including melanoma
02/03/2004US6685934 Neurodegenerative diseases.
02/03/2004CA2123496C A bacillus promoter derived from a variant of a bacillus licheniforms x-amylase promoter
02/03/2004CA2118594C Max: a helix-loop-helix zipper protein that forms a sequence-specific dna-binding complex with myc and mad
02/03/2004CA2095735C Monoclonal antibodies to hepatitis c virus and method for using same
02/03/2004CA2091636C Method for suppressing coloring of human serum albumin
02/03/2004CA2025597C Vaccine against lyme disease
02/03/2004CA1341450C Methods and compositions for the preparation of treponema pallidum antigens, including purified antigens and dna sequences coding therefor
01/2004
01/31/2004CA2432676A1 Development of an in vivo functional assay for proteases
01/31/2004CA2396611A1 Materials and methods for generating genetic disruptions in bacterial cells
01/29/2004WO2004010144A1 Probe carrier and method of producing same
01/29/2004WO2004009848A1 Microparticle based signal amplification for the detection of analytes
01/29/2004WO2004009847A2 Functional screening method involving protein translocation/redistribution
01/29/2004WO2004009843A2 Detection of microorganisms
01/29/2004WO2004009841A2 Method of identifying genes involved in cell growth regulation
01/29/2004WO2004009835A2 Method for identifying cellular growth inhibitors
01/29/2004WO2004009828A1 Method for the biotechnological production of citric acid by means of a genetically-modified yeast yarrowia lipolytica
01/29/2004WO2004009824A2 Pav regions for encapsidation and e1 transcriptioonal control
01/29/2004WO2004009823A1 Method of expressing recombinant protein in cho cells
01/29/2004WO2004009822A2 Use of specific myb genes for the production of transgenic plants tolerant to biotic and abiotic stresses
01/29/2004WO2004009821A1 Method for the production of transgenic plants with increased virus resistance by silencing vegetable dnaj-like proteins
01/29/2004WO2004009820A1 Method for obtaining the pathogenic resistance in plants
01/29/2004WO2004009819A2 Polypeptides with a signal sequence comprising an fivsi motif and olynucleotides encoding therefor
01/29/2004WO2004009818A1 Nucleic acid sequence coding for enzyme delta-12-desaturase and originating from fragilariopsis cylindrus, associated polypeptide, and use of this nucleic acid sequence and polypeptide
01/29/2004WO2004009817A1 Nucleic acid encoding mirafiori lettuce virus protein and utilization thereof
01/29/2004WO2004009816A1 Methods of treating conditions associated with an edg-1 receptor
01/29/2004WO2004009815A2 Silencing hybrid gene expression
01/29/2004WO2004009814A1 Gene shuffling by template switching
01/29/2004WO2004009813A1 METHOD OF CONSTRUCTING NONHUMAN MAMMAL HAVING RNAi PHENOTYPE WITH THE USE OF PAPILOMAVIRUS VECTOR
01/29/2004WO2004009811A1 A gene entrain system with the core sequence of histone
01/29/2004WO2004009810A2 Transgenic animal models of hrv with humani icam-1 sequences
01/29/2004WO2004009808A1 Saccharose-6-phosphate phosphatase as a target for herbicides
01/29/2004WO2004009806A1 Nadh-dependent cytochrome b5 reductase as a target for herbicides
01/29/2004WO2004009803A2 Regulation of human hepsin
01/29/2004WO2004009802A2 gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS
01/29/2004WO2004009799A2 Ion channel receptor and uses thereof
01/29/2004WO2004009797A2 Protein modification and maintenance molecules
01/29/2004WO2004009796A2 Single promoter system for making sirna expression cassettes and expression libraries using a polymerase primer hairpin linker
01/29/2004WO2004009794A2 NOVEL siRNA LIBRARIES AND THEIR PRODUCTION AND USE
01/29/2004WO2004009792A2 Transposon-based vectors and methods of nucleic acid integration
01/29/2004WO2004009790A2 Metastatic colon cancer specific promoter and uses thereof
01/29/2004WO2004009789A2 Targeted adenoviral vector displaying immunoglobulin-binding domain and uses thereof
01/29/2004WO2004009782A2 Methods for generating enhanced antibody-producing cell lines with improved growth characteristics
01/29/2004WO2004009781A2 Process for regulating gene expression
01/29/2004WO2004009779A2 Compositions and methods for the modulation of gene expression in plants